VIV. A. Ivanov

V. A. Ivanov

*This is an algorithmically generated author record based on publicly available information.

V. A. Ivanov has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cardiac surgery for radiation-induced heart disease: a comprehensive assessment of perioperative period with personalized analysis of morphological data

    by Yu.V. Frolova, K.A. Vilizhinskaya, V.A. Ivanov, M.A. Fomin, Ya.A. Aidamirov, I.G. Polozkova, Z.V. Gioeva, M.A. Kozlova, D.A. Areshidze, L.V. Kaktursky, et al.

    Radiotherapy (RT) in combined treatment of mediastinal malignancies currently allows for stable remission. Despite improvements in RT techniques aimed at minimizing total focal dose, ionizing radiation still leads to post-radiation cardiac injury (PRCI) with progressive chronic heart failure (CHF) resistant to standard drug therapy. Cardiac surgery is one of the treatment options for consequences of PRCI. Previous RT for mediastinal malignancies predicts worse short- and long-term postoperative outcomes. Complex radiation-induced damage to all cardiac structures (pericardium, myocardium, coronary arteries, valves and conduction system), severe calcification of ascending aorta and pulmonary fibrosis significantly complicate technical aspects of surgery, increase surgery time and risk of intra- and postoperative complications. Obviously, a detailed analysis of pathophysiological mechanisms of PRCI underlies a personalized approach to the treatment of appropriate patients. Clinical and morphological data will facilitate objective risk stratification, creation of an optimized pharmacological strategy, analysis of timing and extent of cardiac surgery aimed at reducing risks and improving long-term prognosis in these patients.

  • Severe aortic stenosis in surgery of acquired heart disease: long-term results

    by V.A. Ivanov, E.P. Evseev, E.V. Ivanova, L.N. Ivanova, T.G. Nikityuk, M.A. Fomin, Ya.A. Aydamirov, E.V. Balakin

    Objective. To evaluate long-term survival, physical activity, hemodynamic parameters on aortic prosthesis and cardiac remodeling after surgical treatment of severe aortic stenosis. Material and methods. In 2019, we retrospectively analyzed the results of 100 consecutive surgeries in patients with critical aortic stenosis. Appropriate surgical intervention, anesthesia, perfusion and intensive care reduced in-hospital mortality and morbidity in these patients. Ninety-eight patients were discharged. Results. The follow-up period was 7.8 (range 6.3—10.0) years. In long-term period, 6 patients died, and 10-year Kaplan-Meier survival rate was 94%. There were no redo surgeries. Dysfunction of aortic prosthesis was observed in one patient due to pannus. Twenty-five (29%) patients were assigned to functional class I, 59 (69%) — class II, and only 2 (2%) patients were assigned to class III. According to transthoracic echocardiography, maximum and mean pressure gradients were 30.5±14.1 and 16.6±9.6 mm Hg, respectively. Regression of myocardial mass and myocardial mass index was 22% and 23% compared to early postoperative data, respectively. Conclusion. In patients with severe aortic stenosis and extremely unfavorable clinical prognosis, surgical treatment remains the main method. Normalization of intracardiac hemodynamics leads to significant reverse cardiac remodeling and improves QoL and life expectancy.

  • Early cardiac rehabilitation after multivalvular correction of heart defects

    by V.A. Ivanov, E.P. Evseev, E.V. Ivanova, L.N. Ivanova, T.G. Nikityuk, Ya.A. Aidamirov, V.I. Voropaeva, A.A. Botashev

    Objective. To develop a program for early cardiac rehabilitation of patients after surgical correction of multivalvular heart defects. Material and methods. Between 2023 and 2025, 51 patients underwent surgical correction of multivalvular heart disease. They were randomized into two groups: in the first group (24 patients) physical training and respiratory rehabilitation on the Acapella simulator were carried out in addition to standard drug therapy; in the second group (23 people) standard drug therapy was carried out. Results. Objective assessment of cardiac rehabilitation according to 6-minute walk test showed significantly longer distance in the 1st group (425.4±26.4 (NYHA class 1—2) vs. 316.6±14.3 m (NYHA class 2—3)) (p<0.05). Conclusion. The developed program of in-hospital cardiac rehabilitation showed good results. It reduced functional class and improved clinical status of patients. Patients with multivalvular heart defects represent a severe category with longer recovery period. Following the recommendations for lifestyle changes and physical activity after hospitalization contribute to faster recovery and return to full life.

  • Triple valve replacement after recurrent infective endocarditis and previous COVID-19 infection

    by D.A. Podchasov, V.A. Ivanov, E.P. Evseev, Ya.A. Aidamirov, E.V. Ivanova, E.V. Balakin, A.A. Botashev

    The authors present redo mitral valve replacement, aortic valve and tricuspid valve replacement in a patient with recurrent infective endocarditis following COVID-19 infection. This patient with EuroSCORE II 19.24% underwent successful triple valve replacement.

  • Long-term results of multivalvular correction of heart defects

    by V.A. Ivanov, E.P. Evseev, E.V. Ivanova, L.N. Ivanova, T.G. Nikityuk, Ya.A. Aidamirov, E.V. Balakin, M.A. Nechaenko, M.A. Fomin, S.B. Mikhlin, et al.

    Objective. To evaluate the long-term results of surgical correction of multivalvular heart defects. Material and methods. In the department of heart defects surgery, 51 patients underwent replacement of two or more heart valves between 2023 and 2025. In the long-term period, which averaged 19.5±6.3 (9±29) months, 47 patients were examined. Survival was evaluated at the primary endpoint. Functional state by the NYHA, lack of thromboembolic and hemorrhagic complications, heart remodeling and intracardiac hemodynamics according to the echocardiography data, as well as metabolic, cardiovascular indices, parameters of lung ventilation and pulmonary gas exchange according to the data of ergospirometry were assessed at the secondary endpoint. Results. The long-term actuarial survival amounted to 92.5%. Massive gastric hemorrhage due to an anticoagulant overdose was the cause of one fatal case. A clinically significant health improvement has been noted in the majority of patients; functional class I (FC) by the NYHA has been noted in 17 patients (37.5%), FC II by the NYHA — in 25 (54%), FC III by the NYHA — in 4 (8.5%). The absence of hemorrhagic complications by Kaplan-Meyer amounted to 95%, there were no episodes of thromboembolism. According to the ergospirometry, mean values of exercise tolerance and peak oxygen consumption reached 102.1±22.5 W and 15.6±3.4 ml/kg/min, respectively. Conclusion. Surgical correction of multivalvular heart defects allows to significantly improve the intracardiac hemodynamics, survival and functional status in the long-term period as the only effective treatment method for patients in this particularly complex category.

  • Septal myectomy in aortic valve replacement for severe aortic stenosis

    by M.A. Fomin, E.P. Evseev, V.A. Ivanov, T.G. Nikityuk, Yu.V. Belov

    Objective. To analyze the immediate and mid-term results of septal myectomy and aortic valve replacement in patients with severe aortic stenosis. Material and methods. A retro- and prospective analysis included 148 patients with severe aortic stenosis and interventricular septal hypertrophy ≥1.5 cm between 2012 and 2022. Age of patients was 63.0 (60; 66) years. The study included 89 (60%) men and 59 (40%) women. There were 88 patients (60%) with heart failure NYHA class III and 48 (32%) ones with class II. Patients were divided into two groups. Both groups did not differ in clinical and echocardiographic characteristics before surgery. In the AVR+SME group, septal myectomy was performed together with aortic valve replacement. Results. Septal myectomy is a safe procedure not increasing perioperative risk and morbidity in early postoperative period. At the same time, septal myectomy provides better hemodynamic characteristics in the left ventricular outflow tract and aortic valve prosthesis. Mean LVOT pressure gradient was 2.3 (1.8; 2.9) and 4.6 (3.1; 6.8) mm Hg, (p< 0.01), mean pressure gradient on the aortic valve prosthesis — 9.6 (6.2;14.5) and 12.8 (8.2;19.0) mm Hg, respectively (p<0.01). Survival, complication and redo surgery rate in mid-term period were similar. Septal myectomy improves the mid-term results of aortic valve prosthesis and promotes more effective reverse myocardial remodeling after surgery. Left ventricular myocardial mass index in a year after surgery was 90.7 (75.9; 106.9) and 118.4 (100.0; 142.2) g/m2 (p<0.01), respectively. Conclusion. Septal myectomy together with aortic valve replacement improves the results of surgical treatment of aortic stenosis in early and mid-term postoperative period.


  • Immediate results of mitral and aortic valve replacement with simultaneous Cox-Maze IV procedure

    by E.P. Evseev, A.A. Botashev, I.A. Aidamirov, E.V. Balakin, M.A. Fomin, V.A. Ivanov, Yu.V. Belov

    Objective. To evaluate the immediate outcomes of mitral and aortic valve replacement with simultaneous Cox-Maze IV procedure. Material and methods. A retrospective study included 23 patients who underwent mitral and aortic valve replacement with simultaneous Cox-Maze IV procedure between 2017 and 2023. Results. Sinus rhythm at discharge was noted in 17 (81%) patients, atrial fibrillation — in 4 (19%) patients. Postoperative hospital-stay was 9 (7; 10) days. Among patients with paroxysmal AF, sinus rhythm at discharge was restored in 5 (83.3%) out of 6 patients, in persistent AF — 3 (100%) out of 3 patients, in longstanding persistent AF — 9 (75%) out of 12 patients. No cases of permanent pacemaker implantation were observed. Conclusion. Mitral and aortic valve replacement with simultaneous Cox-Maze IV procedure is effective and safe. This approach improves early and long-term outcomes, as well as quality of life.

  • Immediate and long-term results of the simultaneous rhythm-converting procedure Cox-Maze IV in multivalvular correction

    by E.P. Evseev, A.A. Botashev, I.A. Aidamirov, E.V. Balakin, M.A. Fomin, A.O. Fazylov, V.A. Ivanov, Yu.V. Belov

    Objective. This study aimed to investigate the immediate and long-term outcomes of the Cox-Maze IV procedure in patients undergoing surgical treatment for multivalvular heart disease with atrial fibrillation. It also sought to identify predictors of atrial fibrillation recurrence in the long-term period. Materials and methods. We conducted an analysis of 92 patients who underwent multivalvular heart defect correction and simultaneous Cox-Maze IV procedure between 2017 and 2023. The mean age of the patients was 65.5 years (57.5; 69), 43 males (46.7%) and 49 females (53.3%). Sixty-six patients (71.7%) were classified as functional class III heart failure according to NYHA, while 3 (3.3%), 14 (15.2%), and 9 (9.8%) were classified as functional classes I, II, and IV, respectively. The types of atrial fibrillation were: paroxysmal in 15.2%, persistent in 22.8%, and long-standing persistent in 62%. The mean duration of atrial fibrillation prior to surgery was 15.5 months (10; 45.8) for those with paroxysmal form, 7 months (4; 9) for persistent form, and 60 months (22; 84) for long-standing persistent form. Mitral-aortic valve replacement was performed in 9 cases (9.8%), mitral-tricuspid correction in 69 cases (75%), and combined mitral-aortic-tricuspid correction in 14 cases (15.2%). Results. During the hospital stay, there were 3 fatalities. In the long-term follow-up, 8 deaths were recorded, with 3 attributed to cardiac causes. Permanent pacemaker implantation was required in just one case during the long-term postoperative period. The freedom from atrial fibrillation was 61.4% in patients with paroxysmal form at follow-up of up to 46 months, 58.1% in those with persistent form at up to 63 months, and 32.5% in those with long-standing persistent form at up to 82 months. Three predictors of arrhythmia recurrence were identified: early postoperative atrial fibrillation paroxysms, a duration of atrial fibrillation exceeding 60 months, and enlarged left atrial size. Conclusions. The Cox-Maze IV rhythm-conversion procedure designed to restore sustained sinus rhythm is most effective in patients with paroxysmal and persistent forms of atrial fibrillation, achieving success rates of 61.4% and 58.1%, respectively. This procedure is not associated with a high rate of pacemaker implantation. An enlarged left atrium should not deter the use of the Cox-Maze IV procedure in patients with atrial fibrillation; however, atrioplasty is recommended if the left atrium is significantly enlarged. Episodes of rhythm disturbance during the early postoperative period and a history of atrial fibrillation lasting more than 60 months prior to surgery are associated with an increased risk of recurrence postoperatively. Therefore, careful monitoring of these patients after discharge is essential for early detection and management of recurrences.

  • Adapted scale for analysis of necessary septal myectomy in aortic valve replacement

    by M.A. Fomin, E.P. Evseev, E.V. Balakin, Ya.A. Aidamirov, A.A. Botashev, V.A. Ivanov, T.G. Nikityuk

    Objective. To develop the adapted scale for analysis of necessary septal myectomy (SME) in aortic valve replacement (AVR) for severe aortic stenosis. Material and methods. A retrospective and prospective analysis included 180 patients with severe aortic stenosis and interventricular septal hypertrophy ≥1.5 cm who underwent surgery between 2012 and 2024. Age of patients was 64 (61; 67.3) years. There were 96 (53.3%) men and 84 (46.7%) women. Heart failure NYHA class III was observed in 98 patients (54.4%), class II in 54 (30.0%) patients. The AVR+SME group included 100 patients, and the AVR group included 80 patients. Both groups did not differ in preoperative clinical and echocardiography characteristics. Results. Logistic regression was performed to identify significant predictors. Multivariate analysis provided logistic function including 3 predictors: IVST / PWT, indexed LV myocardial mass and aortic annulus diameter. Regression model included significant factors obtained at the first stage of analysis. The obtained prognostic model was significant (p 83.5 indicates advisability of SME in aortic valve replacement. Conclusion. The new scale for predicting the need for SME in AVR will improve postoperative results.